Stockreport

Visiongain Report Claims There is Huge Potential Within the $266bn Biologicals Market

HYPERA SA S/ADR  (HYPMY) 
NASDAQ:AMEX Investor Relations: hypera.riweb.com.br/default.aspx?linguagem=en
PDF LONDON, Oct. 28, 2019 /PRNewswire/ -- The global biologics market is estimated to reach $266bn in 2024. The market is expected to grow at a CAGR of 4.8% from 2019 to 202 [Read more]